| APP-Overexpressing Neurons | |
|---|---|
| Mutation Type | Familial Alzheimer's Disease / Down Syndrome |
| Gene Affected | APP (Amyloid Precursor Protein) |
| Common Mutations | Swedish (K670N/M671L), London (V717I), Indiana (V717F), Flemish (A692G) |
| Mechanism | Increased Aβ production or altered processing |
| Disease | Familial Alzheimer's Disease, Down Syndrome |
App Overexpressing Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
APP-overexpressing neurons are neurons that carry mutations or duplications in the amyloid precursor protein (APP) gene, leading to increased production of amyloid-beta (Aβ) peptides. APP mutations cause familial Alzheimer's disease (FAD) through either increased total Aβ production (Swedish mutation) or shifted processing toward more aggregation-prone species. Additionally, individuals with Down syndrome (trisomy 21) have three copies of APP and develop AD-like pathology by age 40-60.
APP is a transmembrane protein that can be processed through two main pathways:
Amyloidogenic pathway (Aβ-producing):
Non-amyloidogenic pathway:
| Mutation | Location | Effect |
|---|---|---|
| Swedish | APP β-secretase site | 3-6x increased Aβ total production |
| London | APP γ-secretase site | Increased Aβ42 production |
| Indiana | APP γ-secretase site | Increased Aβ42 production |
| Flemish | APP Aβ domain | Increased Aβ40, reduced aggregation |
| Arctic | APP Aβ domain | Enhanced oligomerization |
APP-overexpressing neurons exhibit:
| Feature | APP-Mutant Phenotype | Normal Control |
|---|---|---|
| Aβ production | Elevated (3-10x) | Baseline |
| Plaque formation | Present | Absent |
| Synaptic markers | Reduced | Normal |
| Neuronal viability | Decreased | Stable |
| Oxidative stress | Elevated | Baseline |
APP mutations cause pathology in:
App Overexpressing Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of App Overexpressing Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.